- Home
- CLRO vs BOLT Comparison
CLRO vs BOLT Comparison
Compare CLRO & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRO
- BOLT
- Stock Information
- Founded
- CLRO 1983
- BOLT 2015
- Country
- CLRO United States
- BOLT United States
- Employees
- CLRO N/A
- BOLT N/A
- Industry
- CLRO Radio And Television Broadcasting And Communications Equipment
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- CLRO Technology
- BOLT Health Care
- Exchange
- CLRO Nasdaq
- BOLT Nasdaq
- Market Cap
- CLRO 9.3M
- BOLT 10.4M
- IPO Year
- CLRO N/A
- BOLT 2021
- Fundamental
- Price
- CLRO $5.77
- BOLT $6.17
- Analyst Decision
- CLRO
- BOLT Buy
- Analyst Count
- CLRO 0
- BOLT 3
- Target Price
- CLRO N/A
- BOLT $47.50
- AVG Volume (30 Days)
- CLRO 53.0K
- BOLT 33.8K
- Earning Date
- CLRO 11-14-2025
- BOLT 11-11-2025
- Dividend Yield
- CLRO N/A
- BOLT N/A
- EPS Growth
- CLRO N/A
- BOLT N/A
- EPS
- CLRO N/A
- BOLT N/A
- Revenue
- CLRO $9,689,000.00
- BOLT $4,167,000.00
- Revenue This Year
- CLRO N/A
- BOLT N/A
- Revenue Next Year
- CLRO N/A
- BOLT N/A
- P/E Ratio
- CLRO N/A
- BOLT N/A
- Revenue Growth
- CLRO N/A
- BOLT N/A
- 52 Week Low
- CLRO $3.83
- BOLT $4.59
- 52 Week High
- CLRO $21.00
- BOLT $14.36
- Technical
- Relative Strength Index (RSI)
- CLRO 61.93
- BOLT 63.23
- Support Level
- CLRO $5.53
- BOLT $5.13
- Resistance Level
- CLRO $6.14
- BOLT $6.20
- Average True Range (ATR)
- CLRO 0.46
- BOLT 0.32
- MACD
- CLRO 0.06
- BOLT 0.07
- Stochastic Oscillator
- CLRO 44.17
- BOLT 87.19
About CLRO ClearOne Inc. (DE)
ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.